Radius Health (RDUS) Misses Q4 EPS by 15c

Radius Health (NASDAQ: RDUS) reported Q4 EPS of ($0.33), $0.15 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $65 million versus the consensus estimate of $63.06 million.

For earnings history and earnings-related data on Radius Health (RDUS) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Lumentum shares rise on analyst upgrades, AI demand outlook
• Amneal gets FDA approval for lanreotide injection, launches immediately